California State Teachers Retirement System (CalSTRS)’s Trillium Therapeutics Inc. TRIL Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-53,541	Closed	-$940K	–	3275
2021 Q3	$940K	Sell	53,541 -81,334	-60%	-$950K	﹤0.01%	2182
2021 Q2	$1.31M	Buy	+134,875	New	+$1.27M	﹤0.01%	2033

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s TRIL Position: Q4 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 53,541 shares — an estimated $940K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $1.31M in Q2 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

California State Teachers Retirement System (CalSTRS) reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 53,541 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $940K.
California State Teachers Retirement System (CalSTRS) first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
California State Teachers Retirement System (CalSTRS)'s Trillium Therapeutics Inc. position peaked at $1.31M in Q2 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q4 2021, filed 15 Feb 2022.